N. M. Anstey

696 total citations
9 papers, 528 citations indexed

About

N. M. Anstey is a scholar working on Public Health, Environmental and Occupational Health, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, N. M. Anstey has authored 9 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 3 papers in Computational Theory and Mathematics and 3 papers in Pharmacology. Recurrent topics in N. M. Anstey's work include Malaria Research and Control (8 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Computational Drug Discovery Methods (3 papers). N. M. Anstey is often cited by papers focused on Malaria Research and Control (8 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Computational Drug Discovery Methods (3 papers). N. M. Anstey collaborates with scholars based in Australia, United Kingdom and Indonesia. N. M. Anstey's co-authors include Ric N. Price, Emiliana Tjitra, Enny Kenangalem, Ferdinand Laihad, A. Ratcliff, Hadjar Siswantoro, François Nosten, Rossarin Suwanarusk, Usa Lek‐Uthai and Kim A. Piera and has published in prestigious journals such as The Lancet, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

N. M. Anstey

9 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. M. Anstey Australia 7 497 140 132 89 57 9 528
Hadjar Siswantoro Indonesia 8 524 1.1× 134 1.0× 135 1.0× 104 1.2× 35 0.6× 15 547
Akintunde Sowunmi Nigeria 17 596 1.2× 149 1.1× 126 1.0× 100 1.1× 43 0.8× 51 713
Francis Hombhanje Japan 14 367 0.7× 121 0.9× 114 0.9× 56 0.6× 56 1.0× 37 513
A. Ratcliff Australia 5 436 0.9× 123 0.9× 115 0.9× 78 0.9× 32 0.6× 6 456
Bakary Fofana Mali 14 573 1.2× 121 0.9× 189 1.4× 117 1.3× 47 0.8× 27 605
Eric M. Njunju Zambia 7 547 1.1× 128 0.9× 133 1.0× 99 1.1× 83 1.5× 10 624
Onikepe Folarin Nigeria 14 490 1.0× 141 1.0× 150 1.1× 85 1.0× 60 1.1× 18 522
Dorina Bustos Philippines 12 440 0.9× 109 0.8× 113 0.9× 70 0.8× 56 1.0× 18 484
ME Molyneux United Kingdom 7 516 1.0× 112 0.8× 126 1.0× 75 0.8× 65 1.1× 10 638
Apichart Nontprasert Thailand 11 338 0.7× 92 0.7× 77 0.6× 90 1.0× 66 1.2× 20 488

Countries citing papers authored by N. M. Anstey

Since Specialization
Citations

This map shows the geographic impact of N. M. Anstey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. M. Anstey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. M. Anstey more than expected).

Fields of papers citing papers by N. M. Anstey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. M. Anstey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. M. Anstey. The network helps show where N. M. Anstey may publish in the future.

Co-authorship network of co-authors of N. M. Anstey

This figure shows the co-authorship network connecting the top 25 collaborators of N. M. Anstey. A scholar is included among the top collaborators of N. M. Anstey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. M. Anstey. N. M. Anstey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Anstey, N. M. & Ric N. Price. (2015). The effect of dose on the antimalarial efficacy of artemether–lumefantrine: a systematic review and pooled analysis of individual patient data. The Lancet Infectious Diseases. 15(6). 692–702. 59 indexed citations
2.
3.
Poespoprodjo, Jeanne Rini, Enny Kenangalem, Paulus Sugiarto, et al.. (2011). Highly Effective Therapy for Maternal Malaria Associated With a Lower Risk of Vertical Transmission. The Journal of Infectious Diseases. 204(10). 1613–1619. 30 indexed citations
4.
Lek‐Uthai, Usa, Rossarin Suwanarusk, Ronnatrai Ruengweerayut, et al.. (2008). Stronger Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors against Clinical Isolates of Plasmodium vivax than against Those of P. falciparum. Antimicrobial Agents and Chemotherapy. 52(7). 2435–2441. 33 indexed citations
5.
Suwanarusk, Rossarin, Marina Chavchich, Bruce Russell, et al.. (2008). Amplification ofpvmdr1Associated with Multidrug‐ResistantPlasmodium vivax. The Journal of Infectious Diseases. 198(10). 1558–1564. 104 indexed citations
6.
Thomas, Jane, Mark McMillan, Tsin Wen Yeo, et al.. (2008). Finger reactive hyperaemia to measure endothelial function in sepsis and health (the FRESH study). Critical Care. 12(Suppl 2). P64–P64. 1 indexed citations
7.
Ratcliff, A., Hadjar Siswantoro, Enny Kenangalem, et al.. (2007). Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. The Lancet. 369(9563). 757–765. 208 indexed citations
8.
Price, Ric N., Armedy Ronny Hasugian, A. Ratcliff, et al.. (2007). Clinical and Pharmacological Determinants of the Therapeutic Response to Dihydroartemisinin-Piperaquine for Drug-Resistant Malaria. Antimicrobial Agents and Chemotherapy. 51(11). 4090–4097. 73 indexed citations
9.
Siswantoro, Hadjar, Enny Kenangalem, Ferdinand Laihad, et al.. (2006). Efficacy of existing antimalarial drugs for uncomplicated malaria in Timika, Papua, Indonesia. Medical Journal of Indonesia. 251–251. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026